Rosuvastatin attenuated contrast-induced nephropathy in diabetes patients with renal dysfunction.

Abstract

Rosuvastatin could reduce the effect of degrading glomerular filtration function and renal tubular damage in patients with DM and mild to moderate renal dysfunction.